Furthermore, secondary FLCN alterations were frequently encountered in aggressive thyroid tumors lacking oncocytic morphology, highlighting the complexity of FLCN’s role in thyroid tumorigenesis and underscoring the need for its inclusion in clinical molecular panels for thyroid cancer diagnostics. Here, FLCN is linked to thyroid gland disorder.